Tag: AFT Pharmaceuticals
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
AHMADA welcomes release of new pain relief medication
The Australian Health Manufacturers and Development Association (AHMADA) welcomed the launch of the new medication, MAXIGESIC®, which reduces pain and inflammation.
According to the media...
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
